SE8002222L - Oxytocin-derivat - Google Patents

Oxytocin-derivat

Info

Publication number
SE8002222L
SE8002222L SE8002222A SE8002222A SE8002222L SE 8002222 L SE8002222 L SE 8002222L SE 8002222 A SE8002222 A SE 8002222A SE 8002222 A SE8002222 A SE 8002222A SE 8002222 L SE8002222 L SE 8002222L
Authority
SE
Sweden
Prior art keywords
derivatives
oxytocin
inhibitory effect
new
uterine contractions
Prior art date
Application number
SE8002222A
Other languages
English (en)
Other versions
SE430885B (sv
Inventor
P O R Melin
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8002222A priority Critical patent/SE430885B/sv
Priority to US06/238,715 priority patent/US4402942A/en
Priority to CH140781A priority patent/CH646139A5/de
Priority to GB8106843A priority patent/GB2074582B/en
Priority to DE3108323A priority patent/DE3108323C2/de
Priority to NL8101191A priority patent/NL8101191A/nl
Priority to BE0/204141A priority patent/BE887970A/fr
Priority to JP4227581A priority patent/JPS56150050A/ja
Priority to FR8105751A priority patent/FR2482093A1/fr
Priority to IT20684/81A priority patent/IT1136574B/it
Publication of SE8002222L publication Critical patent/SE8002222L/sv
Publication of SE430885B publication Critical patent/SE430885B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE8002222A 1980-03-24 1980-03-24 Oxytocin-derivat SE430885B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat
US06/238,715 US4402942A (en) 1980-03-24 1981-02-27 Oxytocin derivatives
CH140781A CH646139A5 (de) 1980-03-24 1981-03-03 Oxytocin-derivate.
GB8106843A GB2074582B (en) 1980-03-24 1981-03-04 Oxytocin-derivatives
DE3108323A DE3108323C2 (de) 1980-03-24 1981-03-05 1-Desamino (2-O-alkyltyrosin)-oxytocine und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
NL8101191A NL8101191A (nl) 1980-03-24 1981-03-11 Oxytocine derivaat; farmaceutisch preparaat; werkwijze voor het tegengaan van spiercontracties van de uterus.
BE0/204141A BE887970A (fr) 1980-03-24 1981-03-16 Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
JP4227581A JPS56150050A (en) 1980-03-24 1981-03-23 Oxitocin derivative
FR8105751A FR2482093A1 (fr) 1980-03-24 1981-03-23 Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
IT20684/81A IT1136574B (it) 1980-03-24 1981-03-24 Derivati della ossitocina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat

Publications (2)

Publication Number Publication Date
SE8002222L true SE8002222L (sv) 1981-09-25
SE430885B SE430885B (sv) 1983-12-19

Family

ID=20340577

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat

Country Status (10)

Country Link
US (1) US4402942A (sv)
JP (1) JPS56150050A (sv)
BE (1) BE887970A (sv)
CH (1) CH646139A5 (sv)
DE (1) DE3108323C2 (sv)
FR (1) FR2482093A1 (sv)
GB (1) GB2074582B (sv)
IT (1) IT1136574B (sv)
NL (1) NL8101191A (sv)
SE (1) SE430885B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10075020I2 (de) * 1982-12-21 2003-01-09 Ferring Ab Vasotocinderivate
SE8207277L (sv) * 1982-12-21 1984-06-22 Ferring Ab Vasotocin-derivat
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
US4624943A (en) * 1985-03-20 1986-11-25 Smithkline Beckman Corporation Aromatic basic-tailed vasopressin antagonists
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists
DE4042008A1 (de) * 1990-12-22 1992-06-25 Schering Ag Vasopressin-derivate
US5830848A (en) * 1992-10-09 1998-11-03 The Regents Of The University Of California Method and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancy
US6797845B1 (en) 1999-11-22 2004-09-28 Dow Global Technologies Inc. Process for vinyl chloride manufacture from ethane and ethylene with immediate HCl recovery from reactor effluent
US6933417B1 (en) 1999-11-22 2005-08-23 Dow Global Technologies Inc. Process for vinyl chloride manufacture from ethane and ethylene with partial CHl recovery from reactor effluent
US6680415B1 (en) 1999-11-22 2004-01-20 Dow Global Technologies Inc. Oxyhalogenation process using catalyst having porous rare earth halide support
US6909024B1 (en) * 1999-11-22 2005-06-21 The Dow Chemical Company Process for the conversion of ethylene to vinyl chloride and novel catalyst compositions useful for such process
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
MXPA03010693A (es) * 2001-05-23 2004-07-01 Dow Global Technologies Inc Halogenacion oxidante y deshidreogenacion opcional de hidrocarburos de c3+.
US20040152929A1 (en) * 2002-05-08 2004-08-05 Clarke William D Process for vinyl chloride manufacture from ethane and ethylene with air feed and alternative hcl processing methods
US7722733B2 (en) 2004-03-29 2010-05-25 Baxter International Inc. Method for sterile connection of tubing
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
AU2015338717B2 (en) 2014-10-31 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Powder formulation
JP6933322B2 (ja) 2016-01-04 2021-09-08 メルク セローノ エス．エー． ヒドロキシプロピルチアゾリジンカルボキサミド誘導体のｌ−バリネート及びその塩形態、結晶多形
UA127283C2 (uk) 2016-07-21 2023-07-12 Обсева С.А. Спосіб застосування антагоніста окситоцину для сприяння імплантації ембріона і запобігання викидню
JP7390031B2 (ja) * 2018-12-27 2023-12-01 国立大学法人金沢大学 オキシトシン誘導体及びその使用
CN114667141A (zh) 2019-09-03 2022-06-24 奥布赛瓦股份公司 用于促进胚胎移植和预防流产的催产素拮抗剂给药方案
AU2021218895A1 (en) 2020-02-10 2022-09-15 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
EP4243817A1 (en) 2020-11-16 2023-09-20 Xoma (Us) Llc Compositions and methods for the treatment or prevention of preterm labor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1463865A (fr) * 1964-07-27 1966-07-22 Ceskoslovenska Akademie Ved Procédé pour la préparation des dérivés cycliques de peptides ainsi que les produits conformes à ceux obtenus par le présent procédé ou procédé similaire
CS194980B1 (en) * 1976-07-16 1979-12-31 Joseph H Cort Agent for current induction,fertilization facilitating and milkability increasing at mammals,especially at utility cattle

Also Published As

Publication number Publication date
US4402942A (en) 1983-09-06
FR2482093B1 (sv) 1984-11-09
GB2074582A (en) 1981-11-04
DE3108323C2 (de) 1983-11-24
CH646139A5 (de) 1984-11-15
BE887970A (fr) 1981-07-16
DE3108323A1 (de) 1981-12-24
IT1136574B (it) 1986-09-03
SE430885B (sv) 1983-12-19
GB2074582B (en) 1983-07-06
JPS56150050A (en) 1981-11-20
FR2482093A1 (fr) 1981-11-13
IT8120684A0 (it) 1981-03-24
NL8101191A (nl) 1981-10-16

Similar Documents

Publication Publication Date Title
SE8002222L (sv) Oxytocin-derivat
ES429710A1 (es) Un procedimiento para la preparacion de nuevos n,n'-bis- (beta-hidroxi-ariletil)-diaminoalcanos.
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
TW249804B (sv)
JPS5419990A (en) Dihydrotriazinylthioxacephalosporin
JPS5430184A (en) 3,4-dihydrocarbostyril derivative
ES471672A1 (es) Un procedimiento para la preparacion de un peptido
IL83967A (en) Pharmaceutical compositions comprising antigestagens for the inhibition of uterine synthesis of prostaglandin
ES8307258A1 (es) "procedimiento para la preparacion de nuevas cefalosporinas".
ES474986A1 (es) Procedimiento para la preparacion de derivados de la isoqui-noleina
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.
GB1000783A (en) Improvements in or relating to pharmaceutical compositions containing polyhydroxybenzene derivatives
JPS51125352A (en) Process for preparing 3-methoxy-alpha trifluoromethylphenyl- acetoxycyclope ntene-5-olderivatives
ES441244A1 (es) Metodo de preparar compuestos esteres basicos.
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative
JPS51138660A (en) Process for prep aration of polycyclic urethanes
JPS5419980A (en) Gamma-pyrone and gamma-pyridone derivative
GB931019A (en) Pharmaceutical compositions containing quinazolone compounds
JPS51146474A (en) Process for preparing piperidylbenzimidazole derivatives
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
JPS5214751A (en) Hydroquinone derivatives
JPS5265255A (en) Synthesis of tetrahydronaphthylamine derivatives
JPS527920A (en) Preparation of esters of beta-sulfenylacrylic acid
JPS5271484A (en) Synthesis of novel quinazoline derivatives
JPS5219669A (en) Preparation of tetrazole derivatives and acid addition salts thereof

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8002222-1

Effective date: 19890426

Format of ref document f/p: F